Pancreatic cancer patients whose tumors exhibit high levels of heparanase mRNA had a significantly shorter postoperative survival time than patients whose tumors contained relatively low levels (13, 15, 73). This evidence concerns the gene HPSE and familial pancreatic carcinoma.